Dhar R, Kirkpatrick J, Gilbert L, Khanna A, et al. Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU). PLoS One 2023;18:e0280745.
PMID: 36689456